Ayşe Deniz Ertürk Coşkun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ayşe Deniz Ertürk Coşkun has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Fisun Vural
Department of Gynecology and Obstetrics, University of Health Sciences Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey
5 shared publications - Egemen Tural
Department of Family Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul 34096, Türkiye
2 shared publications Fisun Vural
Department of Gynecology and Obstetrics, University of Health Sciences Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey
2 shared publications- Ahmet Göçmen
Ataşehir medicana hastanesi
1 shared publication Alper Turkoglu
Basaksehir Cam and Sakura City Hospital, Turkey
1 shared publicationAyşe Deniz
1 shared publication
Latest Publications
- Open Access
- 6 June 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Comparison of first trimester complete blood count parameters in missed abortion and healthy pregnant women: a retrospective case-control study
The aim of our study is to compare the markers and parameters obtained from complete blood count between patients diagnosed with missed abortion in the first trimester and a healthy pregnant control group. This descriptive, retrospective, case-control study included 166 patients diagnosed with missed abortion according to ultrasound criteria, and an equal number of healthy pregnant controls, who visited the Gynecology and Obstetrics Clinic at a Training and Research Hospital from January 1, 2018, to July 1, 2023. Participants, with 5 to 14 weeks of gestation, were selected using simple random sampling. Data on age, gravida, parity, gestational week, and hemogram results were retrieved from medical records and compared. Statistical significance was set at p < 0.05. No significant differences were observed between the case and control groups in terms of gravida, parity, age, or gestational week (p > 0.05). Likewise, comparisons of hemogram parameters and derived values, did not show statistically significant differences (p > 0.05). However, the multivariate logistic regression analysis revealed that each unit increase in lymphocyte count was linked to a 2.075 times higher risk of missed abortion (p = 0.040). Our study found no significant differences in complete blood count parameters between the missed abortion and healthy pregnant groups. Although lymphocyte count was significant in the multivariate model, this association should be interpreted with caution, as complete blood count values were obtained at the time of diagnosis. Therefore, it does not indicate predictive value, and prospective studies are needed to determine whether lymphocyte count may serve as a pre-diagnostic marker.
- 6 June 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Open AccessComparison of first trimester complete blood count parameters in missed abortion and healthy pregnant women: a retrospective case-control study
The aim of our study is to compare the markers and parameters obtained from complete blood count between patients diagnosed with missed abortion in the first trimester and a healthy pregnant control group. This descriptive, retrospective, case-control study included 166 patients diagnosed with missed abortion according to ultrasound criteria, and an equal number of healthy pregnant controls, who visited the Gynecology and Obstetrics Clinic at a Training and Research Hospital from January 1, 2018, to July 1, 2023. Participants, with 5 to 14 weeks of gestation, were selected using simple random sampling. Data on age, gravida, parity, gestational week, and hemogram results were retrieved from medical records and compared. Statistical significance was set at p < 0.05. No significant differences were observed between the case and control groups in terms of gravida, parity, age, or gestational week (p > 0.05). Likewise, comparisons of hemogram parameters and derived values, did not show statistically significant differences (p > 0.05). However, the multivariate logistic regression analysis revealed that each unit increase in lymphocyte count was linked to a 2.075 times higher risk of missed abortion (p = 0.040). Our study found no significant differences in complete blood count parameters between the missed abortion and healthy pregnant groups. Although lymphocyte count was significant in the multivariate model, this association should be interpreted with caution, as complete blood count values were obtained at the time of diagnosis. Therefore, it does not indicate predictive value, and prospective studies are needed to determine whether lymphocyte count may serve as a pre-diagnostic marker.
- Open Access
- 1 January 2024
- Published by Universitas Indonesia in Makara Journal of Health Research
- Vol. 28 (2) , 3
Exploring Overactive Bladder Symptoms in Premenopausal and Postmenopausal Women: A Comparative Cross-Sectional Study
Background: Overactive bladder syndrome affects millions globally. It can intermittently cause urinary incontinence, which can significantly diminish the quality of life. This study investigated overactive bladder symptoms in premenopausal and postmenopausal individuals by analyzing the influence of demographic, gynecological, and obstetric factors. Methods: This single-center prospective cross-sectional study was conducted between September 1 and November 1, 2023, among premenopausal and postmenopausal women. In total, 244 patients meeting the inclusion criteria were selected using a simple random method. Participants were asked to complete an information collection form, and the Turkish version of the Overactive Bladder-V8 questionnaire was administered. A significance level of p < 0.05 was considered. Results: Individuals with an overactive bladder were older (mean age, 46.14 ± 14.56) and had a higher body mass index (mean, 28.47 ± 6.02) than healthy individuals (p = 0.013, p < 0.001, respectively). No significant difference in menopausal status was found (p = 0.091). Urinary incontinence was significantly higher in the overactive bladder group (63.6% vs. 17.4%, p < 0.001). The number of vaginal deliveries and prior gynecologic surgeries differed significantly between the groups (p = 0.030, p = 0.001, respectively). Conclusions: Age, higher body mass index, vaginal childbirth, and history of gynecological surgeries are associated with overactive bladder frequency, whereas menopausal status did not exert a significant effect.
- 1 January 2024
- Published by Universitas Indonesia in Makara Journal of Health Research
- Vol. 28 (2) , 3
Open AccessExploring Overactive Bladder Symptoms in Premenopausal and Postmenopausal Women: A Comparative Cross-Sectional Study
Background: Overactive bladder syndrome affects millions globally. It can intermittently cause urinary incontinence, which can significantly diminish the quality of life. This study investigated overactive bladder symptoms in premenopausal and postmenopausal individuals by analyzing the influence of demographic, gynecological, and obstetric factors. Methods: This single-center prospective cross-sectional study was conducted between September 1 and November 1, 2023, among premenopausal and postmenopausal women. In total, 244 patients meeting the inclusion criteria were selected using a simple random method. Participants were asked to complete an information collection form, and the Turkish version of the Overactive Bladder-V8 questionnaire was administered. A significance level of p < 0.05 was considered. Results: Individuals with an overactive bladder were older (mean age, 46.14 ± 14.56) and had a higher body mass index (mean, 28.47 ± 6.02) than healthy individuals (p = 0.013, p < 0.001, respectively). No significant difference in menopausal status was found (p = 0.091). Urinary incontinence was significantly higher in the overactive bladder group (63.6% vs. 17.4%, p < 0.001). The number of vaginal deliveries and prior gynecologic surgeries differed significantly between the groups (p = 0.030, p = 0.001, respectively). Conclusions: Age, higher body mass index, vaginal childbirth, and history of gynecological surgeries are associated with overactive bladder frequency, whereas menopausal status did not exert a significant effect.
- 7 December 2023
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 32 (6) , 1074-1081
Glandular Crowdings in Endometrial Polyps: Clinical Follow-Up and Possible Worrisome Features
Introduction: Interpretation of changes and premalignant lesions in endometrial polyps can be challenging. We evaluated the clinical course of patients with focal gland crowdings in endometrial polyps via repeat biopsies and searched for possible morphological findings in the initial biopsy that may foresee a premalignant course. Methods: Specimens diagnosed as endometrial polyp and focal gland crowding in patients who had a repeat biopsy in a 1-year period were reexamined. Morphological findings in the initial biopsies were recorded. The group whose repeat biopsies were “premalignant or malignant” (Group 1), and the group with “benign” repeat biopsies (Group 2) were compared. Results: “Endometrial polyp and gland crowdings” was diagnosed in 115 specimens of which 38 patients had repeat biopsies. Among these 8 (21%) were diagnosed as “endometrial intraepithelial neoplasia (EIN)” (Group 1) and 30 (79%) as “benign” (Group 2). Morphological features in the initial biopsies were evaluated; PAX2 loss was 6 of 8 (75%) for Group 1 and 7 of 30 (23%) for Group 2 ( P = .020), and altered epithelial cytological features were present in 5 of 8 (62%) versus 4 of 30 (13%) ( P = .015), both significantly higher in Group 1. Dark intraluminal secretion, intraluminal histiocytes, intraglandular epithelial proliferation, and mean diameter of crowded gland areas were not statistically different between the 2 groups. Conclusion: “Focal gland crowdings” in endometrial polyps do carry a risk of EIN in subsequent biopsies. We suggest that the loss/decrease of PAX2 and altered epithelial cytological features in these areas in the initial biopsy are indicative of a premalignant course.
- 7 December 2023
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 32 (6) , 1074-1081
Glandular Crowdings in Endometrial Polyps: Clinical Follow-Up and Possible Worrisome Features
Introduction: Interpretation of changes and premalignant lesions in endometrial polyps can be challenging. We evaluated the clinical course of patients with focal gland crowdings in endometrial polyps via repeat biopsies and searched for possible morphological findings in the initial biopsy that may foresee a premalignant course. Methods: Specimens diagnosed as endometrial polyp and focal gland crowding in patients who had a repeat biopsy in a 1-year period were reexamined. Morphological findings in the initial biopsies were recorded. The group whose repeat biopsies were “premalignant or malignant” (Group 1), and the group with “benign” repeat biopsies (Group 2) were compared. Results: “Endometrial polyp and gland crowdings” was diagnosed in 115 specimens of which 38 patients had repeat biopsies. Among these 8 (21%) were diagnosed as “endometrial intraepithelial neoplasia (EIN)” (Group 1) and 30 (79%) as “benign” (Group 2). Morphological features in the initial biopsies were evaluated; PAX2 loss was 6 of 8 (75%) for Group 1 and 7 of 30 (23%) for Group 2 ( P = .020), and altered epithelial cytological features were present in 5 of 8 (62%) versus 4 of 30 (13%) ( P = .015), both significantly higher in Group 1. Dark intraluminal secretion, intraluminal histiocytes, intraglandular epithelial proliferation, and mean diameter of crowded gland areas were not statistically different between the 2 groups. Conclusion: “Focal gland crowdings” in endometrial polyps do carry a risk of EIN in subsequent biopsies. We suggest that the loss/decrease of PAX2 and altered epithelial cytological features in these areas in the initial biopsy are indicative of a premalignant course.
- 12 July 2023
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 31 (6) , 1093-1098
Ovarian Histology of Removed Ovaries After Gender-Affirming Testosterone Therapy
Introduction. Assigned female at birth transgender people go through a gender-affirming hormone therapy using testosterone. We aimed to define the histological changes in the removed ovaries of these patients and investigate the correlation of these changes to factors like chronological age and duration of hormone therapy. Methods. The ovaries of 84 patients who had at least 6 months of testosterone therapy before surgery were examined. Tunica albuginea thickness, cortical thickness, and number of different stages of follicles were recorded. Results. The mean age was 27.2 ± 4.9 years. Testosterone duration 25.8 ± 13.1 months. The mean tunica albuginea thickness was 356.4 ± 152.6 µm. The mean cortical thickness was 799.6 ± 245.6 µm. The number of primordial (C1) follicles was 18.03 ± 13.6 and antral (C3) follicles was 3.1 ± 1.9 per cm². When grouped as using therapy under or over 2 years the groups did not have differences in histological findings. Hormone duration did not correlate with histological findings except for a positive correlation with atretic follicle number. However, age was negatively correlated with number of follicles at all stages except atretic follicles and positively correlated with cortical thickness ( P < .05). Conclusion. Testosterone therapy induces multifollicularity, stromal hyperplasia, and luteinization in some patients. Hormone duration did not correlate with ovarian histology whereas chronological age did suggesting an effect of age on ovarian reserve rather than duration of hormone therapy.
- 12 July 2023
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 31 (6) , 1093-1098
Ovarian Histology of Removed Ovaries After Gender-Affirming Testosterone Therapy
Introduction. Assigned female at birth transgender people go through a gender-affirming hormone therapy using testosterone. We aimed to define the histological changes in the removed ovaries of these patients and investigate the correlation of these changes to factors like chronological age and duration of hormone therapy. Methods. The ovaries of 84 patients who had at least 6 months of testosterone therapy before surgery were examined. Tunica albuginea thickness, cortical thickness, and number of different stages of follicles were recorded. Results. The mean age was 27.2 ± 4.9 years. Testosterone duration 25.8 ± 13.1 months. The mean tunica albuginea thickness was 356.4 ± 152.6 µm. The mean cortical thickness was 799.6 ± 245.6 µm. The number of primordial (C1) follicles was 18.03 ± 13.6 and antral (C3) follicles was 3.1 ± 1.9 per cm². When grouped as using therapy under or over 2 years the groups did not have differences in histological findings. Hormone duration did not correlate with histological findings except for a positive correlation with atretic follicle number. However, age was negatively correlated with number of follicles at all stages except atretic follicles and positively correlated with cortical thickness ( P < .05). Conclusion. Testosterone therapy induces multifollicularity, stromal hyperplasia, and luteinization in some patients. Hormone duration did not correlate with ovarian histology whereas chronological age did suggesting an effect of age on ovarian reserve rather than duration of hormone therapy.
- 24 December 2022
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 307 (4) , 1083-1090
The diagnostic performance of antimullerian hormone for polycystic ovarian syndrome and polycystic ovarian morphology
Purpose The diagnosis of polycystic ovary syndrome (PCOS) remains a challenge to clinicians due to heterogeneous clinical presentation and diagnostic criteria. This study investigated the utilization of Anti-Müllerian hormone (AMH) alone or replacing polycystic ovarian morphology (PCOM) in the PCOS diagnostic criteria. Methods A total of 401 women were categorised as PCOS (n:154), nonPCOS with polycystic ovarian morphology (PCOM) (n:105), and nonPCOS with normal ovarian morphology (NOM) (n:142). First, the diagnostic performance of AMH for PCOS diagnosis in Rotterdam, Androgen Excess Society, and National Institutes of Health (NIH) criteria was analyzed. Second, AMH was used instead of PCOM in Rotterdam criteria and we searched diagnostic performance for PCOS phenotypes. Results AMH levels were positively correlated with LH, testosterone, hirsutism score, menstrual cycle length, and antral follicle count (p < 0.05). AMH alone had specificity and sensitivity for PCOS diagnosis were 84.9% and 72.4% in Rotterdam (AUC: 0.866); 84.4% and 72% in Androgen Excess Society (AUC: 0.857); 83.3% and 66.4% in National Institute of Health criteria (AUC: 0.825). AMH alone had satisfactory diagnostic potential for phenotype A, but not other phenotypes. The replacement of PCOM with AMH in Rotterdam criteria had a high diagnostic potential for PCOS (AUC: 0.934, sensitivity:97.4%, specificity: 90.67%). Phenotype A and phenotype D were diagnosed with 100% sensitivity and 94.5% specificity. Phenotype C was recognised with 96.15% sensitivity and 94.5% specificity. Conclusion AMH may be used with high diagnostic accuracy instead of PCOM in the Rotterdam PCOS criteria.
- 24 December 2022
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 307 (4) , 1083-1090
The diagnostic performance of antimullerian hormone for polycystic ovarian syndrome and polycystic ovarian morphology
Purpose The diagnosis of polycystic ovary syndrome (PCOS) remains a challenge to clinicians due to heterogeneous clinical presentation and diagnostic criteria. This study investigated the utilization of Anti-Müllerian hormone (AMH) alone or replacing polycystic ovarian morphology (PCOM) in the PCOS diagnostic criteria. Methods A total of 401 women were categorised as PCOS (n:154), nonPCOS with polycystic ovarian morphology (PCOM) (n:105), and nonPCOS with normal ovarian morphology (NOM) (n:142). First, the diagnostic performance of AMH for PCOS diagnosis in Rotterdam, Androgen Excess Society, and National Institutes of Health (NIH) criteria was analyzed. Second, AMH was used instead of PCOM in Rotterdam criteria and we searched diagnostic performance for PCOS phenotypes. Results AMH levels were positively correlated with LH, testosterone, hirsutism score, menstrual cycle length, and antral follicle count (p < 0.05). AMH alone had specificity and sensitivity for PCOS diagnosis were 84.9% and 72.4% in Rotterdam (AUC: 0.866); 84.4% and 72% in Androgen Excess Society (AUC: 0.857); 83.3% and 66.4% in National Institute of Health criteria (AUC: 0.825). AMH alone had satisfactory diagnostic potential for phenotype A, but not other phenotypes. The replacement of PCOM with AMH in Rotterdam criteria had a high diagnostic potential for PCOS (AUC: 0.934, sensitivity:97.4%, specificity: 90.67%). Phenotype A and phenotype D were diagnosed with 100% sensitivity and 94.5% specificity. Phenotype C was recognised with 96.15% sensitivity and 94.5% specificity. Conclusion AMH may be used with high diagnostic accuracy instead of PCOM in the Rotterdam PCOS criteria.
- 27 July 2022
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 48 (11) , 2911-2917
Ultrasonographic measurement of vaginal thickness: Relation to menopausal status and genitourinary syndrome of menopause
Objective: To compare the total vaginal wall thickness (TVT) and total mucosal thickness (TMT) measurements of premenopausal and postmenopausal women measured by ultrasonography and to determine the association of these measurements to findings and symptoms of genitourinary syndrome of menopauseMethods: Healthy volunteers, 80 postmenopausal and 80 premenopausal, were included. Ultrasonographic TVT and TMT measurements, vaginal health index (VHI) scores and pH values were recorded. The daily impact of vaginal aging (DIVA) scale was administered to women in the postmenopausal group.Results: TVT measurements of the postmenopausal group (6.55 ± 2.00 mm) were lower than the premenopausal group (10.37 ± 2.11 mm) (p: 0.000). TMT measurements of the postmenopausal group (1.46 ± 0.50 mm) were lower than the premenopausal group (2.19 ± 0.60 mm) (p: 0.000). The VHI scores of the postmenopausal group were significantly lower than the premenopausal group, the pH value was higher (p < 0.05). Considering all women TVT and TMT measurements were inversely correlated with pH values and positively correlated with total VHI scores. There was no significant correlation between any component scores of the DIVA scale and TVT, TMT, pH, and VHI total (p > 0.05).Conclusions: TVT and TMT measurements in postmenopausal women are significantly lower than premenopausal women. Examination findings and thickness measurements are correlated. Transabdominal ultrasonography is a method that can be used in the evaluation of vaginal thickness which is not painful for the patient, is easy to apply and gives results consistent with the examination findings. However, measurements and examination findings do not correlate with the DIVA scores in postmenopausal women.
- 27 July 2022
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 48 (11) , 2911-2917
Ultrasonographic measurement of vaginal thickness: Relation to menopausal status and genitourinary syndrome of menopause
Objective: To compare the total vaginal wall thickness (TVT) and total mucosal thickness (TMT) measurements of premenopausal and postmenopausal women measured by ultrasonography and to determine the association of these measurements to findings and symptoms of genitourinary syndrome of menopauseMethods: Healthy volunteers, 80 postmenopausal and 80 premenopausal, were included. Ultrasonographic TVT and TMT measurements, vaginal health index (VHI) scores and pH values were recorded. The daily impact of vaginal aging (DIVA) scale was administered to women in the postmenopausal group.Results: TVT measurements of the postmenopausal group (6.55 ± 2.00 mm) were lower than the premenopausal group (10.37 ± 2.11 mm) (p: 0.000). TMT measurements of the postmenopausal group (1.46 ± 0.50 mm) were lower than the premenopausal group (2.19 ± 0.60 mm) (p: 0.000). The VHI scores of the postmenopausal group were significantly lower than the premenopausal group, the pH value was higher (p < 0.05). Considering all women TVT and TMT measurements were inversely correlated with pH values and positively correlated with total VHI scores. There was no significant correlation between any component scores of the DIVA scale and TVT, TMT, pH, and VHI total (p > 0.05).Conclusions: TVT and TMT measurements in postmenopausal women are significantly lower than premenopausal women. Examination findings and thickness measurements are correlated. Transabdominal ultrasonography is a method that can be used in the evaluation of vaginal thickness which is not painful for the patient, is easy to apply and gives results consistent with the examination findings. However, measurements and examination findings do not correlate with the DIVA scores in postmenopausal women.
- 1 June 2022
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 307 (2) , 565-571
The relationship of endometrial pathologies with endometrial thickness and inflammatory markers in breast cancers using tamoxifen
Purpose Some proliferative and neoplastic changes can be seen in the endometrium of breast cancers using tamoxifen adjuvant therapy (TMX-BC). Identifying risk groups is crucial, but methods and frequency of endometrial follow-up are still controversial. This study aimed to investigate the clinical, ultrasonographic, and inflammatory factors to differentiate pathological endometrium in TMX-BC. Methods This study retrospectively analyzed endometrial biopsy results of TMX-BC (n 361). Normal endometrium (Group I, n 237) and pathological endometrium (Group II, n 124) were compared for clinical, ultrasonographic, and inflammatory features. Neutrophil and platelet to lymphocyte ratio (NLR; PLR), mean platelet volume (MPV), platelet distribution width (PDW), red blood cell distribution width (RDW), and lymphocyte–monocyte ratio (LMR) were the inflammatory markers. Results The majority of TMX-BC with endometrial biopsy were asymptomatic (72.6%) and had normal endometrium (65.7%). Pathologic endometrium included endometrial polyp (31.9%), endometrial hyperplasia (1.7%), and endometrial cancer (0.8%). The duration of tamoxifen, cancer stage, vaginal bleeding, and menopause was similar in Group I and Group II (p > 0.05). Group II had increased endometrial thickness (11.22 ± 5.44 mm) compared to Group I (8.51 ± 3.43 mm). Group II had higher RDW and PDW than Group I (p < 0.05). Endometrial thickness ≥ 10 mm had significant diagnostic potential in postmenopausal women (AUC 0.676, p 0.000, CI 0.5–0.7), but not in premenopause. Conclusion PDW and RDW may be promising markers for pathological endometrium differentiation, but these preliminary findings should be validated by clinical studies. Measurement of endometrial thickness in asymptomatic patients may predict high-risk women with pathological endometrium in postmenopausal women. Further studies are needed in premenopausal women and those using tamoxifen for more than 5 years.
- 1 June 2022
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 307 (2) , 565-571
The relationship of endometrial pathologies with endometrial thickness and inflammatory markers in breast cancers using tamoxifen
Purpose Some proliferative and neoplastic changes can be seen in the endometrium of breast cancers using tamoxifen adjuvant therapy (TMX-BC). Identifying risk groups is crucial, but methods and frequency of endometrial follow-up are still controversial. This study aimed to investigate the clinical, ultrasonographic, and inflammatory factors to differentiate pathological endometrium in TMX-BC. Methods This study retrospectively analyzed endometrial biopsy results of TMX-BC (n 361). Normal endometrium (Group I, n 237) and pathological endometrium (Group II, n 124) were compared for clinical, ultrasonographic, and inflammatory features. Neutrophil and platelet to lymphocyte ratio (NLR; PLR), mean platelet volume (MPV), platelet distribution width (PDW), red blood cell distribution width (RDW), and lymphocyte–monocyte ratio (LMR) were the inflammatory markers. Results The majority of TMX-BC with endometrial biopsy were asymptomatic (72.6%) and had normal endometrium (65.7%). Pathologic endometrium included endometrial polyp (31.9%), endometrial hyperplasia (1.7%), and endometrial cancer (0.8%). The duration of tamoxifen, cancer stage, vaginal bleeding, and menopause was similar in Group I and Group II (p > 0.05). Group II had increased endometrial thickness (11.22 ± 5.44 mm) compared to Group I (8.51 ± 3.43 mm). Group II had higher RDW and PDW than Group I (p < 0.05). Endometrial thickness ≥ 10 mm had significant diagnostic potential in postmenopausal women (AUC 0.676, p 0.000, CI 0.5–0.7), but not in premenopause. Conclusion PDW and RDW may be promising markers for pathological endometrium differentiation, but these preliminary findings should be validated by clinical studies. Measurement of endometrial thickness in asymptomatic patients may predict high-risk women with pathological endometrium in postmenopausal women. Further studies are needed in premenopausal women and those using tamoxifen for more than 5 years.
- 30 April 2022
- Published by Maltepe T脹p Dergisi in Maltepe Tıp Dergisi
Geçirilmiş sezaryen öyküsü olan hastalarda ikinci trimester tarama testi biyokimyasal belirteçlerinin kötü gebelik sonuçlarıyla ilişkisi
Aim: The purpose of this study is to investigate the association between maternal serum levels of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), unconjugatedestriol (uE3) and poor pregnancy outcomes, determine whether these markers are effective predictors of poor pregnancy outcomes and to compare their levels in women with prior cesarean section and no prior uterine surgery. Material and Methods: Women with cesarean section due to a previous uterine surgery (n= 87) and women with no prior uterine surgery and performed vaginal delivery (n= 105) whose prenatal care was performed in the same clinic were included. Second trimester maternal serum levels of AFP, HCG and uE3, as well as multiples of the median (MoM) of these markers were evaluated. Differences in biochemical marker levels between groups and their relationship to poor maternal-fetal outcomes were assessed. Results: AFP, HCG, and uE3 levels of second trimester screening test markers, no statistically significant difference was found between the groups. When both groups are evaluated together, there is a negative, statistically significant association between neonatal weight and AFP level. When comparing the presence of fetal complications and the biochemical markers of the second trimester screening test HCG and E3, no statistically significant difference was observed. It was found that AFP levels of cases with fetal complications were statistically significantly higher than those of cases without fetal complications (p<0.01). Conclusion: While high AFP-MoM levels may be a warning of fetal complications, second trimester screening test markers were found to be insufficient to predict maternal complications. The levels of these markers was not different between women with prior cesarean section or no prior uterine surgery. Conducting this study with a larger sample could provide further valuable information.
- 30 April 2022
- Published by Maltepe T脹p Dergisi in Maltepe Tıp Dergisi
Geçirilmiş sezaryen öyküsü olan hastalarda ikinci trimester tarama testi biyokimyasal belirteçlerinin kötü gebelik sonuçlarıyla ilişkisi
Aim: The purpose of this study is to investigate the association between maternal serum levels of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), unconjugatedestriol (uE3) and poor pregnancy outcomes, determine whether these markers are effective predictors of poor pregnancy outcomes and to compare their levels in women with prior cesarean section and no prior uterine surgery. Material and Methods: Women with cesarean section due to a previous uterine surgery (n= 87) and women with no prior uterine surgery and performed vaginal delivery (n= 105) whose prenatal care was performed in the same clinic were included. Second trimester maternal serum levels of AFP, HCG and uE3, as well as multiples of the median (MoM) of these markers were evaluated. Differences in biochemical marker levels between groups and their relationship to poor maternal-fetal outcomes were assessed. Results: AFP, HCG, and uE3 levels of second trimester screening test markers, no statistically significant difference was found between the groups. When both groups are evaluated together, there is a negative, statistically significant association between neonatal weight and AFP level. When comparing the presence of fetal complications and the biochemical markers of the second trimester screening test HCG and E3, no statistically significant difference was observed. It was found that AFP levels of cases with fetal complications were statistically significantly higher than those of cases without fetal complications (p<0.01). Conclusion: While high AFP-MoM levels may be a warning of fetal complications, second trimester screening test markers were found to be insufficient to predict maternal complications. The levels of these markers was not different between women with prior cesarean section or no prior uterine surgery. Conducting this study with a larger sample could provide further valuable information.
- Open Access
- 1 January 2022
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 48 (1) , 70-77
The role of transperineal ultrasound in the evaluation of stress urinary incontinence cases
To evaluate the use of transperineal ultrasonography while diagnosing stress urinary incontinence (SUI) by comparing the urethral angle (α), posterior urethrovesical angle (β), and bladder neck descent (BND) during rest and Valsalva maneuver in continent women and women with SUI. This prospective observational study was conducted with 50 women with SUI and 50 continent women. Transperineal ultrasonography was performed at rest and during Valsalva maneuver. Q-tip test was performed. During the Valsalva maneuver, both α and β angles were significantly higher in women with SUI (p <0.001). The difference between Valsalva and rest measurements of α and β angles (R α, R β) were also significantly higher in women with SUI (p <0.001). The cut-off point determined for the R α in the diagnosis of stress incontinence was 16° (80% sensitivity, 98% specificity). A statistically significant strong correlation was found between Q-tip test angle and R α value (p=0.000; r=0.890). Q-tip VAS pain scores were significantly higher than ultrasonography VAS pain scores (p <0.001). In relation to the bladder neck descent comparison between the two groups showed that BND was significantly higher in SUI group (p 11mm (90% sensitivity, 98% specificity). Transperineal ultrasonography is a practical, reliable, non-invasive and comfortable method for evaluation of SUI. It has the advantage of dynamic evaluation during the Valsalva maneuver. Rotation angles and BND have high sensitivity and specificity for detection of SUI. The change in α angle with Valsalva (Rα) can be used as an alternative to Q-tip test.
- 1 January 2022
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 48 (1) , 70-77
Open AccessThe role of transperineal ultrasound in the evaluation of stress urinary incontinence cases
To evaluate the use of transperineal ultrasonography while diagnosing stress urinary incontinence (SUI) by comparing the urethral angle (α), posterior urethrovesical angle (β), and bladder neck descent (BND) during rest and Valsalva maneuver in continent women and women with SUI. This prospective observational study was conducted with 50 women with SUI and 50 continent women. Transperineal ultrasonography was performed at rest and during Valsalva maneuver. Q-tip test was performed. During the Valsalva maneuver, both α and β angles were significantly higher in women with SUI (p <0.001). The difference between Valsalva and rest measurements of α and β angles (R α, R β) were also significantly higher in women with SUI (p <0.001). The cut-off point determined for the R α in the diagnosis of stress incontinence was 16° (80% sensitivity, 98% specificity). A statistically significant strong correlation was found between Q-tip test angle and R α value (p=0.000; r=0.890). Q-tip VAS pain scores were significantly higher than ultrasonography VAS pain scores (p <0.001). In relation to the bladder neck descent comparison between the two groups showed that BND was significantly higher in SUI group (p 11mm (90% sensitivity, 98% specificity). Transperineal ultrasonography is a practical, reliable, non-invasive and comfortable method for evaluation of SUI. It has the advantage of dynamic evaluation during the Valsalva maneuver. Rotation angles and BND have high sensitivity and specificity for detection of SUI. The change in α angle with Valsalva (Rα) can be used as an alternative to Q-tip test.
- Open Access
- 1 July 2021
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 67 (7) , 966-970
Comparison of nonspecific inflammatory markers in endometrial cancer and hyperplasia
OBJECTIVE: This study aims to analyze inflammatory markers among patients with endometrial cancer, hyperplasia with atypia/ endometrial intraepithelial neoplasia, hyperplasia without atypia, and normal controls, thus observing the stage at which inflammation becomes the most significant. METHODS: A total of 444 patients who had endometrial sampling were included in the study (endometrial cancer, n=79; endometrial hyperplasia with atypia/endometrial intraepithelial neoplasia, n=27; endometrial hyperplasia without atypia, n=238; and normal controls, n=100). Neutrophil count, lymphocyte count, platelet count, platelet distribution width, neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, CA-125, and endometrial thickness of the patients were recorded. RESULTS: Comparing the groups for neutrophil count, the hyperplasia with atypia group had higher values compared with both the hyperplasia without atypia group and the control group (p=0.003). When compared for the lymphocyte count, the hyperplasia with atypia group had lower values compared with the control group (p=0.014). Neutrophil/lymphocyte ratio of the hyperplasia with atypia group was higher than all other groups, and neutrophil/lymphocyte ratio of the cancer group was higher than the control group (p=0.001). Platelet count, mean platelet volume, platelet distribution width, and platelet/lymphocyte ratio values were not significantly different among groups (p>0.05). CONCLUSIONS: Considering the inflammatory markers, the most prominent result was that the hyperplasia with atypia group had neutrophilia, lymphopenia, and increased neutrophil/lymphocyte ratio compared with other groups.
- 1 July 2021
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 67 (7) , 966-970
Open AccessComparison of nonspecific inflammatory markers in endometrial cancer and hyperplasia
OBJECTIVE: This study aims to analyze inflammatory markers among patients with endometrial cancer, hyperplasia with atypia/ endometrial intraepithelial neoplasia, hyperplasia without atypia, and normal controls, thus observing the stage at which inflammation becomes the most significant. METHODS: A total of 444 patients who had endometrial sampling were included in the study (endometrial cancer, n=79; endometrial hyperplasia with atypia/endometrial intraepithelial neoplasia, n=27; endometrial hyperplasia without atypia, n=238; and normal controls, n=100). Neutrophil count, lymphocyte count, platelet count, platelet distribution width, neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, CA-125, and endometrial thickness of the patients were recorded. RESULTS: Comparing the groups for neutrophil count, the hyperplasia with atypia group had higher values compared with both the hyperplasia without atypia group and the control group (p=0.003). When compared for the lymphocyte count, the hyperplasia with atypia group had lower values compared with the control group (p=0.014). Neutrophil/lymphocyte ratio of the hyperplasia with atypia group was higher than all other groups, and neutrophil/lymphocyte ratio of the cancer group was higher than the control group (p=0.001). Platelet count, mean platelet volume, platelet distribution width, and platelet/lymphocyte ratio values were not significantly different among groups (p>0.05). CONCLUSIONS: Considering the inflammatory markers, the most prominent result was that the hyperplasia with atypia group had neutrophilia, lymphopenia, and increased neutrophil/lymphocyte ratio compared with other groups.